article thumbnail

Personal responsibility in the obesity epidemic

World of DTC Marketing

Mike always battled weight issues, but since he went out on disability, he had gained more weight, leading to diabetes. An unhealthy diet is one of the leading risk factors for poor health and accounts for up to 45% of all deaths from these cardiometabolic diseases, the researchers noted. That’s about $375 per month.

Food 207
article thumbnail

2022 spells change for EU pharmaceutical legislation

European Pharmaceutical Review

This suggests that any of the modelled changes to the regulation could lead to a decrease in the number of OMPs developed… Some of the assessed changes to the regulation could undermine the business model under which OMP?focused THE EUROPEAN PARLIAMENT AND THE COUNCIL OF THE EUROPEAN UNION; 2006. Amsterdam: Gupta Strategists; 2019.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Chiesi expands rare disease portfolio with Amryt Pharma acquisition

pharmaphorum

Supported by voting agreements from leading Amryt shareholders and directors, and unanimously approved and recommended by the boards of both companies, the total transaction is worth up to $1.48 Biopharma and healthcare group Chiesi Farmaceutici S.p.A. is to acquire the 2015-established Amryt Pharma Plc. in an all-cash transaction at $14.50

Pharma 98
article thumbnail

Making an Impact During Disease Awareness Days, Weeks, and Months

PM360

In 2006, Facebook boomed in mainstream popularity and MySpace was one of the most visited websites. In a world that is so driven by metrics, data, and ROI, it’s easy to write off awareness campaigns as unsuccessful or unimpactful if they aren’t driving sales or directly leading to better outcomes.

Media 92
article thumbnail

Market outlook to 2032: future trends across the seven major markets

European Pharmaceutical Review

billion by 2023, driven by the launch of Merck’s Belsomra and Eisai’s lemborexant (E-2006). GlobalData’s Analyst covering Neurology and Ophthalmology, Thomas Parker, MPharmacol, predicted that Belsomra would lead the market by 2023. million in sales by 2032. percent sales expected in 2032 within the seven major markets.

article thumbnail

Air National Guard Wins 3rd Annual Stevie® Award for Hiring and Recruiting Program of the Year

The Brooks Group

The honors are presented by the Stevie Awards®, which organize several of the world's leading business accolade shows, including the prestigious American Business Awards. These nominations follow TBG's 2006 win as Consulting Sales Organization of the Year. We congratulate all of the Finalists on their achievement."

article thumbnail

Air National Guard Wins 3rd Annual Stevie® Award for Hiring and Recruiting Program of the Year

The Brooks Group

The honors are presented by the Stevie Awards®, which organize several of the world's leading business accolade shows, including the prestigious American Business Awards. These nominations follow TBG's 2006 win as Consulting Sales Organization of the Year. We congratulate all of the Finalists on their achievement."